All results
515 results
-
1305-0014 (FIBRONEERTM IPF)
This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older. If they…
- Ages
- 40 Years - N/A
- Sexes
- All
-
1305-0023 (FIBRONEERTM ILD)
This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic Pulmonary…
- Ages
- 18 Years - N/A
- Sexes
- All
-
1Florida ADRC
-
7089 PAL-LIVER
This is a comparative effectiveness study of two pragmatic models aiming to introduce palliative care for end stage liver disease patients. The 2 comparators…
- Ages
- 18 Years - 120 Years
- Sexes
- All
-
9001-303 (ENVISION)
The study will evaluate the safety and efficacy of delandistrogene moxeparvovec gene transfer therapy in non-ambulatory and ambulatory males with DMD. This is…
- Ages
- N/A - N/A
- Sexes
- Male
-
A 5-year Longitudinal Observational Study of Patients With NAFL or NASH
TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual…
- Ages
- 2 Years - N/A
- Sexes
- All
-
A Long-term Observational Study Evaluating Eteplirsen in DMD
-
A Multi-Center, Open-Label, Phase 1/2 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity
AB-101 is an off-the shelf, allogeneic cell product made of "natural killer" cells, also called NK cells. White blood cells are part of the immune system and…
- Ages
- 18 Years - N/A
- Sexes
- All
-
A Pilot Study of Rapid Haplotyping procedure for Personalized Dosing of Dichloroacetate (DCA) in Hea
The purpose of this study is to identify and analyze the frequency of GSTZ1 haplotypes in a healthy adult population and determine the pharmacokinetics of…
- Ages
- 18 Years - 70 Years
- Sexes
- All
-
A Study of ASP1002 in Adults for Treatment of Solid Tumors
ASP1002 is a potential new treatment for people with certain solid tumors. Before ASP1002 is available as a treatment, the researchers need to understand how…
- Ages
- 18 Years - N/A
- Sexes
- All